Chemical Compound

cefepime

CAS Registry Number 97164-57-3
Back to search Request a Quote
cefepime chemical structure
Primary Record

cefepime

In stock
1,837 g
Purity
98.1 %
CAS
97164-57-3

Compound Identifiers & Properties

CAS
97164-57-3
PubChem CID
5464190
SMILES
C[N+]1(CCCC1)CC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)/C(=N/OC)/C4=CSC(=N4)N)SC2)C(=O)[O-]
Canonical SMILES
CO/N=C(/C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[N+]3(C)CCCC3)CS[C@H]12)c1csc(N)n1

Names & Synonyms

  • cefepime
  • Cefepime, E-
  • E-Cefepime
  • Anti-cefepime
  • Anticefepime
  • Cefepima
  • Cefepimum
  • Maxipime
  • Cefepime EP Impurity A
  • Cefepimum [Latin]
  • Cefepima [Spanish]
  • Cefepime Impurity A
  • Cefepime related compound A
  • Cefepime, BMY-2
  • Cefepime impurity A [EP]
  • Anticefepime (>90%)
  • Cefepime [USAN:INN]
  • AC1NUZ1E
  • RefChem:1081315
  • UNII-807PW4VQE3
  • Cefepime [USAN:INN:BAN]
  • Arginine mixture with cefepime
  • BIDD:GT0809
  • Cefepime mixture with arginine
  • DTXSID60164213
  • 97164-57-3
  • UNII-Z0114Q3738
  • Cefepime related compound A [USP]
  • Cefepime specified impurity A [EP]
  • DTXCID1086704
  • SCHEMBL27794664
  • C19H24N6O5S2
  • HVFLCNVBZFFHBT-ZKDACBOMSA-N
  • BMY 28142
  • Cefepime Hydrochloride EP Impurity A
  • Z0114Q3738
  • 88040-23-7
  • AKOS015895225
  • BMY-28142 L-arginine dihydrochloride
  • C19-H24-N6-O5-S2
  • CID5464190
  • 149261-27-8
  • CEFEPIME IMPURITY A [EP IMPURITY]
  • C6H14N4O2.C19H24N6O5S2.2ClH
  • CEFEPIME IMPURITY A (REFERENCE GRADE)
  • Cefepime dihydrochloride monohydrate impurity A [EP]
  • CEFEPIME RELATED COMPOUND A [USP IMPURITY]
  • (6R,7R)-7-[[(2E)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
  • Q27294816
  • (6R,7R)-7-(((2E)-(2-Aminothiazol-4-yl)(methoxyimino)acetyl)amino)-3-((1-methylpyrrolidinio)methyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate
  • C6-H14-N4-O2.C19-H24-N6-O5-S2.2Cl-H
  • B1370-153673
  • (6R,7R)-7-((E)-2-(2-Aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-((1-methylpyrrolidin-1-ium-1-yl)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
  • 143892-90-4
  • Pyrrolidinium, 1-((7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methyl-, (6R-(6alpha,7beta(E)))-
  • CEFEPIME DIHYDROCHLORIDE MONOHYDRATE IMPURITY A [EP IMPURITY]
  • (6R,7R)-7-[[(2E)-2-(2-aminothiazol-4-yl)-2-methoxyimino-acetyl]amino]-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
  • (6R,7R)-7-[[(2Z)-2-(2-AMINO-1,3-THIAZOL-4-YL)-2-METHOXYIMINO-ACETYL]AMINO]-3-[(1-METHYL-2,3,4,5-TETRAHYDROPYRROL-1-YL)METHYL]-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLATE
  • (6R,7R)-7-{[(2E)-2-(2-Amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetyl]amino}-3-[(1-methylpyrrolidin-1-ium-1-yl)methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
  • -7-[[ -2- -2-methoxyimino-acetyl]amino]-3-[ methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
  • [6R-[6.alpha.,7.beta.(Z)]]-1-[[7-[[(2-Amino-4-thiazolyl)(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methylpyrrolidinium, hydroxide, inner salt
  • 1-(((6R,7R)-7-(2-(2-Amino-4-thiazolyl)glyoxylamido)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-methylpyrrolidinium hydroxide, inner salt, 7(sup 2)-(Z)-(O-methyloxime)
  • 1-[[(6R,7R)-7-[[(2E)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-pyrrolidinium inner salt
  • 1-[[(6R,7R)-7-[[(2E)-2-(2-Amino-4-thiazolyl)-2-(methoxyimino)acetyl]amino]-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl]methyl]-1-methyl-pyrrolidinium inner salt; Cefepime Impurity A; Cefepime EP Impurity A
  • PYRROLIDINIUM, 1-((7-(((2-AMINO-4-THIAZOLYL)(METHOXYIMINO)ACETYL)AMINO)-2-CARBOXY-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-EN-3-YL)METHYL)-1-METHYL-, (6R-(6.ALPHA.,7.BETA.(E)))-